Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders

NCT02249676 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Devic's Syndrome
Devic's Neuromyelitis Optica
Devic Syndrome
Devic's Disease
Devic Disease

Interventions

BIOLOGICAL: Autologous mesenchymal stem cells

Sponsor

Tianjin Medical University General Hospital